Currently, there is a lack of robust clinical data regarding the safety of Serrapeptase in pregnant women. Because there have been no controlled human studies to confirm its safety for the developing fetus, most healthcare providers and medical guidelines advise avoiding it while trying to conceive, during pregnancy, and while breastfeeding.
"Teratogenicity" refers to the ability of a substance to cause birth defects. Because Serrapeptase is classified as a supplement in many countries rather than a strictly regulated drug, large-scale studies on how it crosses the placenta or affects fetal development have not been conducted. Without proof of safety, the default medical stance is to avoid it. serrapeptase for pregnancy